Association of two apolipoprotein A-I gene MspI polymorphisms with lipid and blood pressure levels

International Journal of Cardiology

Volumn 102, Issue 2, 2005, Pages 309-314

  Yan, Qing Ma ^a   Thomas, G Neil ^b   Tomlinson, Brian ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apolipoprotein A I; Chinese; Hypertension; Lipids; Metabolic syndrome; Polymorphisms

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CAUCASIAN; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HYPERCHLOREMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RACE DIFFERENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ALLELES; APOLIPOPROTEIN A-I; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CHOLESTEROL, HDL; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; GLYCOPROTEINS; HONG KONG; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 20744452806     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.10.017     Document Type: Article

References (33)

1. O.L. Francone, A. Gurakar, and C. Fielding Distribution and functions of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. Evidence for a functional unit containing these activities together with apolipoproteins A-I and D that catalyzes the esterification and transfer of cell-derived cholesterol J Biol Chem 264 1989 7066 7072
2. O.L. Francone, L. Royer, and M. Haghpassand Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes J Lipid Res 37 1996 1268 1277
3. P.J. Barter, and K.A. Rye High density lipoproteins and coronary heart disease Atherosclerosis 121 1996 1 12
4. D. Hausmann, J.A. Johnson, K. Sudhir, W.L. Mullen, G. Friedrich, and P.J. Fitzgerald Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolaemia and familial combined hyperlipidaemia: correlation with high density lipoproteins J Am Coll Cardiol 27 1996 1562 1570
5. U. Goldbourt, S. Yaari, and J.H. Medalie Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men Arterioscler Thromb Vasc Biol 17 1997 107 113
6. S.E. Nissen, T. Tsunoda, E.M. Tuzcu, P. Schoenhagen, C. Cooper, and M. Yasin Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial JAMA 290 2003 2292 2300
7. A. von Eckardstein, M. Walter, H. Holz, A. Benninghoven, and G. Assmann Site-specific methionine sulfoxide formation is the structural basis of chromatographic heterogeneity of apolipoproteins A-I, C-II, and C-III J Lipid Res 32 1991 1465 1476
8. F. Pagani, A. Sidoli, G.A. Giudici, L. Barenghi, C. Vergani, and F.E. Baralle Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia J Lipid Res 31 1990 1371 1377
9. F. Civeira, M. Pocovi, A. Cenarro, C. Garces, and J.M. Ordovas Adenine for guanine substitution -78 base pairs 5′ to the apolipoprotein (APO) A-I gene: relation with high density lipoprotein cholesterol and APO A-I concentrations Clin Genet 44 1993 307 312
10. E.W. Needham, R.K. Mattu, A. Rees, J. Stocks, and D.J. Galton A polymorphism in the human apolipoprotein AI promoter region: a study in hypertriglyceridaemic patients Hum Hered 44 1994 94 99
11. N. Saha, J.S. Tay, P.S. Low, and S.E. Humphries Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI levels in Chinese non-smokers Genet Epidemiol 11 1994 255 264
12. M.I. Kamboh, C.E. Aston, C.M. Nestlerode, A.E. McAllister, and R.F. Hamman Haplotype analysis of two APOA-I/MspI polymorphisms in relation to plasma levels of apo A-I and HDL-cholesterol Atherosclerosis 127 1996 255 262
13. X.L. Wang, S.X. Liu, R.M. McCredie, and D.E. Wilcken Polymorphisms at the 5′-end of the apolipoprotein AI gene and severity of coronary artery disease J Clin Invest 98 1996 372 377
14. Q.H. Meng, P. Pajukanta, L. Valsta, A. Aro, P. Pietinen, and M.J. Tikkanen Influence of apolipoprotein A-I promoter polymorphism on lipid levels and responses to dietary change in Finnish adults J Intern Med 241 1997 373 378
15. H. Paul-Hayase, M. Rosseneu, D. Robinson, J.P. Van Bervliet, J.P. Deslypere, and S.E. Humphries Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations Hum Genet 88 1992 439 446
16. G. Sigurdsson Jr., V. Gudnason, G. Sigurdsson, and S.E. Humphries Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of HDL and apo A-I Arterioscler Thromb 12 1992 1017 1022
17. C.F. Xu, F. Angelico, M. Del Ben, and S. Humphries Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls Genet Epidemiol 10 1993 113 122
18. E. Angotti, E. Mele, F. Costanzo, and E.V. Avvedimento A polymorphism (G→A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency J Biol Chem 269 1994 17371 17374
19. A.M. Kessling, B. Horsthemke, and S.E. Humohries A study of DNA polymorphisms around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals Clin Genet 28 1985 296 306
20. X.L. Wang, R. Badenhop, K.E. Humphrey, and D.E. Wilcken C to T and/or G to A transitions are responsible for loss of a MspI restriction site at the 5′-end of the human apolipoprotein AI gene Hum Genet 95 1995 473 474
21. X.L. Wang, R. Badenhop, K.E. Humphrey, and D.E. Wilcken New MspI polymorphism at +83 bp of the human apolipoprotein AI gene: association with increased circulating high density lipoprotein cholesterol levels Genet Epidemiol 13 1996 1 10
22. Q. Zhang, Y. Liu, B.W. Liu, P. Fan, J. Cavanna, and D.J. Galton Common genetic variants of lipoprotein lipase and apolipoproteins AI-CIII that relate to coronary artery disease: a study in Chinese and European subjects Molec Genet Metab 64 1998 177 183
23. E.D. Janus for the Cardiovascular Risk Factor Prevalence Study Group Hong Kong Cardiovascular Risk Factor Prevalence Study 1995-1996 Hong Kong 1997 1 145
24. M.J. Stampfer, F.M. Sacks, S. Salvini, W.C. Willett, and C.H. Hennekens A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction N Engl J Med 325 1991 373 381
25. J.J. Badimon, V. Fuster, and L. Badimon Role of high density lipoproteins in the regression of atherosclerosis Circulation 86 1992 III86 III94
26. J. Steinmetz, E. Boerwinkle, R. Gueguen, S. Visvikis, J. Henny, and G. Siest Multivariate genetic analysis of high density lipoprotein particles Atherosclerosis 92 1992 219 227
27. R.A. Norum, J.B. Lakier, S. Goldstein, A. Angel, R.B. Goldberg, and W.D. Block Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease N Engl J Med 306 1982 1513 1519
28. J.H. Wu, M.S. Wen, S.K. Lo, and D. Wu DNA polymorphisms of apolipoprotein B in the population of Taiwan J Formos Med Assoc 92 1993 330 335
29. J.D. Smith, E.A. Brinton, and J.L. Breslow Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro J Clin Invest 89 1992 1796 1800
30. R.A. Hegele, J.H. Brunt, and P.W. Connelly Genetic and biochemical factors associated with variation in blood pressure in a genetic isolate Hypertension 27 1996 308 312
31. D.A. Wu, X.D. Bu, C.H. Warden, D.D.C. Shen, C.Y. Jeng, and W.H.H. Sheu Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene locus on chromosome 8p22 J Clin Invest 97 1996 2111 2118
32. Y.Q. Ma, G.N. Thomas, J.A. Critchley, Z.S. Lee, J.C. Chan, and B. Tomlinson Association of the D8S282 marker near the lipoprotein lipase gene locus with systolic blood pressure in healthy Chinese subjects J Hypertens 20 2002 2199 2204
33. A. Pujia, A. Gnasso, D. Siclari, A. Dominijanni, A. Zingone, and O. Marasco SstI RFLP and hypertension as risk factors for extracoronary atherosclerosis in a male population of southern Italy Artery 21 1994 208 221